liver-directed therapy
Showing 1 - 25 of >10,000
Carcinoma, Hepatocellular, Liver Cell Carcinoma Trial in New Brunswick (Tislelizumab)
Recruiting
- Carcinoma, Hepatocellular
- Liver Cell Carcinoma
-
New Brunswick, New Jersey
- +1 more
Sep 27, 2022
Metastatic Malignant Tumor in the Liver, Neuroendocrine Tumor Trial in San Francisco (procedure, biological, device)
Recruiting
- Metastatic Malignant Neoplasm in the Liver
- Neuroendocrine Neoplasm
- Arterial Embolization
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 22, 2022
Surgery-Complications Trial in Villejuif (individualized GDFT, Restrictive fluid therapy strategy)
Recruiting
- Surgery-Complications
- individualized GDFT
- Restrictive fluid therapy strategy
-
Villejuif, VAL DE Marne, FrancePAUL BROUSSE, centre hepato -biliaire
Jan 19, 2023
Liver Cancer Trial in Durham (Quality of life questionnaires)
Recruiting
- Liver Cancer
- Quality of life questionnaires
-
Durham, North Carolina
- +1 more
Aug 10, 2022
Acetaminophen Exposure Trial in Denver (Acetaminophen)
Withdrawn
- Acetaminophen Exposure
-
Denver, ColoradoUniversity of Colorado Denver
Aug 27, 2021
Hepatocellular Carcinoma, Cirrhosis, Liver Failure Trial in New Orleans (Branch Chain Amino Acid, maltodextrin)
Withdrawn
- Hepatocellular Carcinoma
- +2 more
- Branch Chain Amino Acid
- maltodextrin
-
New Orleans, LouisianaUniversity Medical Center New Orleans
Jan 13, 2022
Liver Metastases Trial in Houston (Leucovorin, 5-FLUOROURACIL, Oxaliplatin)
Recruiting
- Liver Metastases
- Leucovorin
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Apr 26, 2022
Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)
Recruiting
- Small-cell Lung Cancer
- Carboplatin
- +3 more
-
New York, New YorkColumbia University Irving Medical Center, Herbert Irving Compre
Apr 7, 2022
Goal-directed Fluid Therapy on Postoperative Complications
Completed
- Liver Diseases
- Pancreas Disease
- EV1000 platform
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Feb 21, 2022
Ventilator Lung, Liver Cirrhosis, Hepatocellular Carcinoma Trial in Seoul (conventional tidal volume (tidal volume [ml]= ideal
Not yet recruiting
- Ventilator Lung
- +3 more
- conventional tidal volume (tidal volume [ml]= ideal body weight [kg]* 10~12) group
- low tidal (tidal volume [ml]= ideal body weight [kg] * 6~8) volume
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 3, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer Trial in Seattle (Computed Tomography, Single
Recruiting
- Hepatocellular Carcinoma
- +5 more
- Computed Tomography
- +2 more
-
Seattle, Washington
- +1 more
Feb 24, 2022
Liver Diseases Trial (fresh frozen plasma, prothrombin complex concentrate)
Not yet recruiting
- Liver Diseases
- fresh frozen plasma
- prothrombin complex concentrate
- (no location specified)
Nov 16, 2023
Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary
Recruiting
- Breast Cancer
- +2 more
- Systemic therapy for 12 weeks after primary registration
- +3 more
-
Tokyo, JapanTokyo Medical and Dental Univetsity
Nov 15, 2023
Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Cairo (radiation, procedure, other)
Recruiting
- Breast Cancer
- +2 more
- Stereotactic Ablative Radiation Therapy
- +2 more
-
Cairo, EgyptNational Cancer Institute
Nov 20, 2023
Liver Carcinoma, Hepatic Cell Carcinoma Trial in Wuhan (CAR-GPC3 T cells)
Recruiting
- Liver Carcinoma
- Hepatic Cell Carcinoma
- CAR-GPC3 T cells
-
Wuhan, Hubei, ChinaTao Zhang
Nov 20, 2023
Surgery Trial (Goal-directed therapy)
Not yet recruiting
- Surgery
- Goal-directed therapy
- (no location specified)
Jul 19, 2023
Fluid Loss, Enhanced Recovery Trial in New Delhi (Goal directed Fluid Therapy, Conventional Fluid Therapy)
Recruiting
- Fluid Loss
- Enhanced Recovery
- Goal directed Fluid Therapy
- Conventional Fluid Therapy
-
New Delhi, Please Select, IndiaAnita Kulkarni
Sep 6, 2023
Neuroendocrine Tumors, Gastrointestinal Tumors, Carcinoid Tumors Trial in Denver, Kansas City, Nashville (Lanreotide, Y-90
Terminated
- Neuroendocrine Tumors
- +2 more
- Lanreotide
- Y-90 microspheres
-
Denver, Colorado
- +2 more
Jul 5, 2022
Anesthesia, ERAS, Fluid Overload Trial (Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index, standard
Not yet recruiting
- Anesthesia
- +3 more
- Goal-Directed Fluid Therapy guided by Inferior Vena Cava Collapsibility Index
- standard fluid management
- (no location specified)
Nov 10, 2023
Kidney Injury, Acute Trial in Ghent (Early goal directed therapy during 6 hours after occurence of the early phase of acute
Withdrawn
- Kidney Injury, Acute
- Early goal directed therapy during 6 hours after occurence of the early phase of acute kidney injury
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 15, 2022
Renal Injury, Acute Kidney Injury Trial (Goal Directed Fluid Therapy)
Not yet recruiting
- Renal Injury
- Acute Kidney Injury
- Goal Directed Fluid Therapy
- (no location specified)
Oct 25, 2023
Hypotension During Surgery Trial (Plasma-lyte, Norepinephrine)
Not yet recruiting
- Hypotension During Surgery
- (no location specified)
Oct 10, 2023
Pulmonary Embolism Trial in New York (Anticoagulant Therapy, Catheter-Directed Therapy)
Not yet recruiting
- Pulmonary Embolism
- Anticoagulant Therapy
- Catheter-Directed Therapy
-
New York, New YorkNYU Langone Health - Tisch Hospital
Oct 18, 2022
(GDMT) Optimization and Adherence Longitudinal Study for Heart
Not yet recruiting
- Heart Failure
-
Durham, North Carolina
- +3 more
Jun 7, 2023